abnormal hepatocyte morphology, abnormal induced retina neovascularization, abnormal liver development, abnormal lymphangiogenesis, abnormal mandibular prominence morphology, abnormal nervous system development, abnormal retina vasculature morphology, abnormal second pharyngeal arch morphology, abnormal trigeminal ganglion morphology, abnormal vascular development, abnormal vasculogenesis, absent fourth pharyngeal arch, absent organized vascular network, absent third pharyngeal arch, absent visceral yolk sac blood islands, absent vitelline blood vessels, behavior/neurological phenotype, cardiovascular system phenotype, decreased body size, decreased embryo size, decreased total retina thickness, embryo tissue necrosis, embryonic lethality during organogenesis, complete penetrance, embryonic lethality, complete penetrance, enlarged lymphatic vessel, failure of chorioallantoic fusion, heart hemorrhage, homeostasis/metabolism phenotype, impaired cranial neural crest cell differentiation, impaired hematopoiesis, increased susceptibility to injury, lethality throughout fetal growth and development, complete penetrance, liver/biliary system phenotype, lymphatic vessel hyperplasia, nervous system phenotype, no abnormal phenotype detected, perinatal lethality, incomplete penetrance, persistence of hyaloid vascular system, postnatal lethality, complete penetrance, thin retina inner plexiform layer, vision/eye phenotype